|
|
|
| Disease burden of leukemia in Jiangsu Province from 1990 to 2019 |
| MA Zhaojun1, LI Weiwei1, DONG Jianmei1, ZHOU Jinyi2, HAN Renqiang2, QIN Xucheng1
|
1. Department of Chronic Non-communicable Diseases Control and Prevention, Lianyungang Center for Disease Control and Prevention, Lianyungang, Jiangsu 222003, China;
2. Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu 210029, China |
|
|
|
|
Abstract Objective To investigate the trends in the disease burden of leukemia in Jiangsu Province from 1990 to 2019, so as to provide insights into leukemia control in Jiangsu Province. Methods The prevalence, incidence, death and disability adjusted life years (DALYs) of leukemia in Jiangsu Province from 1990 to 2019 were retrieved from the 2019 Global Burden of Disease Study (GBD 2019) database, and standardized by the age structure of Chinese populations in 2000. The trends in the disease burden of leukemia in Jiangsu Province from 1990 to 2019 were analyzed using average annual percent change (AAPC). Results The average annual standardized prevalence, incidence, mortality and DALY rate of leukemia were 63.63/105, 9.76/105, 4.10/105 and 194.83/105 in Jiangsu Province from 1990 to 2019, respectively. The average annual standardized prevalence (AAPC=1.420%, t=5.644, P<0.001) and incidence (AAPC=0.806%, t=3.505, P<0.001) of leukemia appeared a tendency towards a rise, while the average annual standardized mortality (AAPC=-1.589%, t=-14.714, P<0.001) and DALY rate (AAPC=-1.849%, t=-9.046, P<0.001) of leukemia appeared a tendency towards a decline in Jiangsu Province from 1990 to 2019. Higher average annual standardized prevalence (65.27/105 vs. 62.38/105, P<0.001), incidence (10.32/105 vs. 9.29/105, P<0.001), mortality (4.69/105 vs. 3.57/105, P<0.001) and DALY rate of leukemia (216.94/105 vs. 172.80/105, P<0.001) were estimated among men than among women. The crude prevalence of leukemia peaked among patients at ages of 0 to 14 years and 60 to 74 years, and the crude incidence, DALY rate and mortality of leukemia peaked at ages of 0 to 14 years and 75 years and older. Conclusions The mortality and DALY of leukemia appeared a tendency towards a decline and the prevalence and incidence appeared a tendency towards a rise in Jiangsu Province from 1990 to 2019; however, there were high disease burdens of leukemia among men, children and the elderly.
|
|
Received: 13 September 2022
Revised: 12 January 2023
Published: 17 April 2023
|
|
|
| About author:: 江苏省卫生计生委预防医学科研课题（Y2015030） |
|
|
|
[1] 雷蕾,陆翘楚,杜一骏,等.1990—2019年中国0~14岁儿童白血病疾病负担分析[J].卫生软科学,2022,36(12):79-84.
[2] 戴萌娜,袭燕,尹文强,等.中国居民1990—2019年白血病疾病负担趋势分析[J].中国公共卫生,2022,38(5):539-546.
[3] 陈伟锋,宇传华,胡樱.1990—2017年中国白血病疾病负担分析[J].中国慢性病预防与控制,2021,29(10):797-800.
[4] 国家癌症中心.2019中国肿瘤登记年报[M].北京:人民卫生出版社,2021.
[5] 武鸣,周金意.江苏省恶性肿瘤报告(2020)[M].南京:东南大学出版社,2021.
[6] GBD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990—2019:a systematic analysis for the Global Burden of Disease Study 2019BD 2019 Diseases and Injuries Collaborators.Global burden of 369 diseases and injuries in 204 countries and territories,1990—2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396:1204-1222.
[7] 应江伟,杜灵彬,郑艳泽,等.浙江省肿瘤登记地区2000—2009年白血病发病与死亡分析[J].中国肿瘤,2014,20(7):538-542.
[8] ZHOU Q,HONG D,LU J,et al.Pediatric medical care system in China has significantly reduced abandonment of acute lymphoblastic leukemia treatment[J].J Pediatr Hematol Oncol,2015,37(3):181-184.
[9] MIRANDA-FILHO A,PINEROS M,FERLAY J,et al.Epidemiological patterns of leukaemia in 184 countries:a population-based study[J].Lancet Haematol,2018,5(1):14-24.
[10] 王一然. 河南省儿童白血病发病风险预测模型的建立[D].郑州:郑州大学,2018.
[11] 中华人民共和国卫生部.关于开展提高农村儿童重大疾病医疗保障水平试点工作的意见[EB/OL].[2023-01-12].http://www.gov.cn/zwgk/2010-06/10/content_1624580.htm.
[12] 中华人民共和国国家卫生健康委员会,民政部,国家医疗保障局,等.关于开展儿童血液病、恶性肿瘤医疗救治及保障管理工作的通知[EB/OL].[2023-01-12].http://www.gov.cn/zhengce/zhengceku/2019-11/18/content_5453137.htm. |
|
|
|
